Rosetta Genomics Ltd
OTC:ROSGQ
Rosetta Genomics Ltd
OTC:ROSGQ
Price:
0.0001 USD
Updated:
Apr 29, 2024
Rosetta Genomics Ltd
Cash from Operating Activities
|
Rosetta Genomics Ltd
Cash from Operating Activities Peer Comparison
Comparables:
CLGN
KMDA
URGN
ENTX
B
BONS
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Rosetta Genomics Ltd
OTC:ROSGQ
|
Cash from Operating Activities
-$10.4m
|
CAGR 3-Years
1%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
|
|
Collplant Biotechnologies Ltd
NASDAQ:CLGN
|
Cash from Operating Activities
-$2.8m
|
CAGR 3-Years
15%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
N/A
|
|
|
Kamada Ltd
NASDAQ:KMDA
|
Cash from Operating Activities
$4.3m
|
CAGR 3-Years
-39%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
N/A
|
|
|
Urogen Pharma Ltd
NASDAQ:URGN
|
Cash from Operating Activities
-$76.4m
|
CAGR 3-Years
10%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
N/A
|
|
|
Entera Bio Ltd
NASDAQ:ENTX
|
Cash from Operating Activities
-$7.3m
|
CAGR 3-Years
12%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
B
|
Bonus Biogroup Ltd
TASE:BONS
|
Cash from Operating Activities
-₪26.5m
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
-12%
|
See Also
What is Rosetta Genomics Ltd's Cash from Operating Activities?
Cash from Operating Activities
-10.4m
USD
-10.4m
USD
Based on the financial report for Dec 31, 2016, Rosetta Genomics Ltd's Cash from Operating Activities amounts to -10.4m USD.
What is Rosetta Genomics Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
2%
2%
Over the last year, the Cash from Operating Activities growth was 39%. The average annual Cash from Operating Activities growth rates for Rosetta Genomics Ltd have been 1% over the past three years , 2% over the past five years .
You don't have any saved screeners yet
